Decreased expression of apelin in placentas from severe pre-eclampsia patients

References

• Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365:785–99
   PubMed Web of Science ®Google Scholar
• Hall DR, Odendaal HJ, Steyn DW, Grove D. Expectant management of early onset, severe pre-eclampsia: maternal outcome. BJOG 2000;107:1252–7
   PubMed Web of Science ®Google Scholar
• Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001;357:53–6
   PubMed Web of Science ®Google Scholar
• Woodage T, Venter JC, Broder S. Application of the human genome to obstetrics and gynecology. Clin Obstet Gynecol 2002;45:711–32
   PubMedGoogle Scholar
• Cross JC. The genetics of pre-eclampsia: a feto-placental or maternal problem? Clin Genet 2003;64:96–103
   PubMed Web of Science ®Google Scholar
• Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111:649–58
   PubMed Web of Science ®Google Scholar
• Venkatesha S, Toporsian M, Lam C, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006;12:642–9
   PubMed Web of Science ®Google Scholar
• Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672–83
   PubMed Web of Science ®Google Scholar
• Levine RJ, Lam C, Qian C, et al.; C PEP Study Group. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006;355:992–1005
   PubMed Web of Science ®Google Scholar
• Barnes G, Japp AG, Newby DE. Translational promise of the apelin–APJ system. Heart 2010;96:1011–16
   PubMed Web of Science ®Google Scholar
• Tatemoto K, Hosoya M, Habata Y, et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 1998;251:471–6
   PubMed Web of Science ®Google Scholar
• Hosoya M, Kawamata Y, Fukusumi S, et al. Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin. J Biol Chem 2000;275:21061–7
   PubMed Web of Science ®Google Scholar
• Lee DK, Cheng R, Nguyen T, et al. Characterization of apelin, the ligand for the APJ receptor. J Neurochem 2000;74:34–41
   PubMed Web of Science ®Google Scholar
• De Falco M, De Luca L, Onori N, et al. Apelin expression in normal human tissues. In Vivo 2002;16:333–6
   PubMed Web of Science ®Google Scholar
• Kasai A, Shintani N, Oda M, et al. Apelin is a novel angiogenic factor in retinal endothelial cells. Biochem Biophys Res Commun 2004;325:395–400
   PubMed Web of Science ®Google Scholar
• Cox CM, D'Agostino SL, Miller MK, et al. Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo. Dev Biol 2006;296:177–89
   PubMed Web of Science ®Google Scholar
• Kidoya H, Ueno M, Yamada Y, et al. Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis. EMBO J 2008;27:522–34
   PubMed Web of Science ®Google Scholar
• Nishizawa H, Pryor-Koishi K, Kato T, et al. Microarray analysis of differentially expressed fetal genes in placental tissue derived from early and late onset severe pre-eclampsia. Placenta 2007;28:487–97
   PubMed Web of Science ®Google Scholar
• Nishizawa H, Ota S, Suzuki M, et al. Comparative gene expression profiling of placentas from patients with severe pre-eclampsia and unexplained fetal growth restriction. Reprod Biol Endocrinol 2011;9:107
   PubMed Web of Science ®Google Scholar
• Van Mieghem T, van Bree R, Van Herck E, et al. Maternal apelin physiology during rat pregnancy: the role of the placenta. Placenta 2010;31:725–30
   PubMed Web of Science ®Google Scholar
• Cobellis L, De Falco M, Mastrogiacomo A, et al. Modulation of apelin and APJ receptor in normal and preeclampsia-complicated placentas. Histol Histopathol 2007;22:1–8
   PubMed Web of Science ®Google Scholar
• Liao YM, Qiao FY. Expression of Apelin in placentas of patients with hypertensive disorders complicating pregnancy. Zhonghua Fu Chan Ke Za Zhi 2007;42:382–5
   PubMedGoogle Scholar
• Simsek Y, Celik O, Yilmaz E, et al. Serum levels of apelin, salusin-alpha and salusin-beta in normal pregnancy and preeclampsia. J Matern Fetal Neonatal Med 2012;25:1705–8
   PubMed Web of Science ®Google Scholar
• Bortoff KD, Qiu C, Runyon S, et al. Decreased maternal plasma apelin concentrations in preeclampsia. Hypertens Pregnancy 2012;31:398–404
   PubMed Web of Science ®Google Scholar
• ACOG Committee on Obstetric Practice: ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Int J Gynaecol Obstet 2002;77:67–75
   Google Scholar
• van Diest PJ, van Dam P, Henzen-Logmans SC, et al. A scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG. European Organization for Research and Treatment of Cancer-Gynaecological Cancer Cooperative Group. J Clin Pathol 1997;50:801–4
   PubMed Web of Science ®Google Scholar
• Atluri P, Morine KJ, Liao GP, et al. Ischemic heart failure enhances endogenous myocardial apelin and APJ receptor expression. Cell Mol Biol Lett 2007;12:127–38
   Google Scholar
• Masri B, Knibiehler B, Audigier Y. Apelin signalling: a promising pathway from cloning to pharmacology. Cell Signal 2005;17:415–26
   PubMed Web of Science ®Google Scholar
• Kaufmann P, Black S, Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 2003;69:1–7
   PubMed Web of Science ®Google Scholar
• Levy R, Nelson DM. To be, or not to be, that is the question. Apoptosis in human trophoblast. Placenta 2000;21:1–13
   PubMed Web of Science ®Google Scholar
• Heazell AE, Crocker IP. Live and let die – regulation of villous trophoblast apoptosis in normal and abnormal pregnancies. Placenta 2008;29:772–83
   PubMed Web of Science ®Google Scholar
• Kidoya H, Naito H, Takakura N. Apelin induces enlarged and nonleaky blood vessels for functional recovery from ischemia. Blood 2010;115:3166–74
   PubMed Web of Science ®Google Scholar
• Kasai A, Ishimaru Y, Kinjo T, et al. Apelin is a crucial factor for hypoxia-induced retinal angiogenesis. Arterioscler Thromb Vasc Biol 2010;30:2182–7
   PubMed Web of Science ®Google Scholar
• Raymond D, Peterson E. A critical review of early-onset and late-onset preeclampsia. Obstet Gynecol Surv 2011;66:497–506
   PubMed Web of Science ®Google Scholar
• Tatemoto K, Takayama K, Zou MX, et al. The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul Pept 2001;99:87–92
   PubMed Web of Science ®Google Scholar
• Briana DD, Malamitsi-Puchner A. Reviews: adipocytokines in normal and complicated pregnancies. Reprod Sci 2009;16:921–37
   PubMed Web of Science ®Google Scholar
• Page NM. The endocrinology of pre-eclampsia. Clin Endocrinol 2002;57:413–23
   PubMed Web of Science ®Google Scholar
• Anim-Nyame N, Sooranna SR, Steer PJ, Johnson MR. Longitudinal analysis of maternal plasma leptin concentrations during normal pregnancy and pre-eclampsia. Hum Reprod 2000;15:2033–6
   PubMed Web of Science ®Google Scholar
• Kleinz MJ, Davenport AP. Emerging roles of apelin in biology and medicine. Pharmacol Ther 2005;107:198–211
   PubMed Web of Science ®Google Scholar
• Lee DK, George SR, O'Dowd BF. Unravelling the roles of the apelin system: prospective therapeutic applications in heart failure and obesity. Trends Pharmacol Sci 2006;27:190–4
   PubMed Web of Science ®Google Scholar
• Kumasawa K, Ikawa M, Kidoya H, et al. Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model. Proc Natl Acad Sci U S A 2011;108:1451–5
   PubMed Web of Science ®Google Scholar